Although 90–95% of DM patients are insulin-independent type (type 2 diabetes, T2D), the pancreatic islet undergoes a malfunction or dysfunction that results in a loss of an insulin-secretion ability during disease progression and leads to a need to replenish insulin [10]. This evidence concerns the gene INS and type 2 diabetes mellitus.